| Review Article Online Published: 09 Sep 2026 | ||||||||||||
Efficacy and Safety of Basal Insulin Combined with GLP-1 Receptors Agonists versus Intensified Conventional Insulin Regimens in Type 2 Diabetes: A Meta Analysis of Randomized Controlled Trials Sarah Musallam Albishri, Reema Alshaya, Eyas Alharbi, Alshayma Alharbi, Lujain Alharbi, Muath Alferadi, Yara Alfuraydi, Ahmed Alzahrani, Mathahir Almeshal, Rand Alqahtani, Khalid Abdulrahman Althobaiti.
| ||||||||||||
| How to Cite this Article |
| Pubmed Style Albishri SM, Alshaya R, Alharbi E, Alharbi A, Alharbi L, Alferadi M, Alfuraydi Y, Alzahrani A, Almeshal M, Alqahtani R, Althobaiti KA. Efficacy and Safety of Basal Insulin Combined with GLP-1 Receptors Agonists versus Intensified Conventional Insulin Regimens in Type 2 Diabetes: A Meta Analysis of Randomized Controlled Trials. IJMDC. Online First: 09 Sep, 2026. doi:10.24911/IJMDC.51-1785039096 Web Style Albishri SM, Alshaya R, Alharbi E, Alharbi A, Alharbi L, Alferadi M, Alfuraydi Y, Alzahrani A, Almeshal M, Alqahtani R, Althobaiti KA. Efficacy and Safety of Basal Insulin Combined with GLP-1 Receptors Agonists versus Intensified Conventional Insulin Regimens in Type 2 Diabetes: A Meta Analysis of Randomized Controlled Trials. https://www.ijmdc.com/?mno=329009 [Access: September 09, 2026]. doi:10.24911/IJMDC.51-1785039096 AMA (American Medical Association) Style Albishri SM, Alshaya R, Alharbi E, Alharbi A, Alharbi L, Alferadi M, Alfuraydi Y, Alzahrani A, Almeshal M, Alqahtani R, Althobaiti KA. Efficacy and Safety of Basal Insulin Combined with GLP-1 Receptors Agonists versus Intensified Conventional Insulin Regimens in Type 2 Diabetes: A Meta Analysis of Randomized Controlled Trials. IJMDC. Online First: 09 Sep, 2026. doi:10.24911/IJMDC.51-1785039096 Vancouver/ICMJE Style Albishri SM, Alshaya R, Alharbi E, Alharbi A, Alharbi L, Alferadi M, Alfuraydi Y, Alzahrani A, Almeshal M, Alqahtani R, Althobaiti KA. Efficacy and Safety of Basal Insulin Combined with GLP-1 Receptors Agonists versus Intensified Conventional Insulin Regimens in Type 2 Diabetes: A Meta Analysis of Randomized Controlled Trials. IJMDC, [cited September 09, 2026]; Online First: 09 Sep, 2026. doi:10.24911/IJMDC.51-1785039096 Harvard Style Albishri, S. M., Alshaya, . R., Alharbi, . E., Alharbi, . A., Alharbi, . L., Alferadi, . M., Alfuraydi, . Y., Alzahrani, . A., Almeshal, . M., Alqahtani, . R. & Althobaiti, . K. A. (0) Efficacy and Safety of Basal Insulin Combined with GLP-1 Receptors Agonists versus Intensified Conventional Insulin Regimens in Type 2 Diabetes: A Meta Analysis of Randomized Controlled Trials. IJMDC, Online First: 09 Sep, 2026. doi:10.24911/IJMDC.51-1785039096 Turabian Style Albishri, Sarah Musallam, Reema Alshaya, Eyas Alharbi, Alshayma Alharbi, Lujain Alharbi, Muath Alferadi, Yara Alfuraydi, Ahmed Alzahrani, Mathahir Almeshal, Rand Alqahtani, and Khalid Abdulrahman Althobaiti. 0. Efficacy and Safety of Basal Insulin Combined with GLP-1 Receptors Agonists versus Intensified Conventional Insulin Regimens in Type 2 Diabetes: A Meta Analysis of Randomized Controlled Trials. International Journal of Medicine in Developing Countries, Online First: 09 Sep, 2026. doi:10.24911/IJMDC.51-1785039096 Chicago Style Albishri, Sarah Musallam, Reema Alshaya, Eyas Alharbi, Alshayma Alharbi, Lujain Alharbi, Muath Alferadi, Yara Alfuraydi, Ahmed Alzahrani, Mathahir Almeshal, Rand Alqahtani, and Khalid Abdulrahman Althobaiti. "Efficacy and Safety of Basal Insulin Combined with GLP-1 Receptors Agonists versus Intensified Conventional Insulin Regimens in Type 2 Diabetes: A Meta Analysis of Randomized Controlled Trials." International Journal of Medicine in Developing Countries Online First: 09 Sep, 2026. doi:10.24911/IJMDC.51-1785039096 MLA (The Modern Language Association) Style Albishri, Sarah Musallam, Reema Alshaya, Eyas Alharbi, Alshayma Alharbi, Lujain Alharbi, Muath Alferadi, Yara Alfuraydi, Ahmed Alzahrani, Mathahir Almeshal, Rand Alqahtani, and Khalid Abdulrahman Althobaiti. "Efficacy and Safety of Basal Insulin Combined with GLP-1 Receptors Agonists versus Intensified Conventional Insulin Regimens in Type 2 Diabetes: A Meta Analysis of Randomized Controlled Trials." International Journal of Medicine in Developing Countries Online First: 09 Sep, 2026. Web. 09 Sep 2026 doi:10.24911/IJMDC.51-1785039096 APA (American Psychological Association) Style Albishri, S. M., Alshaya, . R., Alharbi, . E., Alharbi, . A., Alharbi, . L., Alferadi, . M., Alfuraydi, . Y., Alzahrani, . A., Almeshal, . M., Alqahtani, . R. & Althobaiti, . K. A. (0) Efficacy and Safety of Basal Insulin Combined with GLP-1 Receptors Agonists versus Intensified Conventional Insulin Regimens in Type 2 Diabetes: A Meta Analysis of Randomized Controlled Trials. International Journal of Medicine in Developing Countries, Online First: 09 Sep, 2026. doi:10.24911/IJMDC.51-1785039096 |